{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:53:06Z","timestamp":1776297186495,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ackdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1053\/j.ackd.2015.03.003","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T02:48:00Z","timestamp":1434422880000},"page":"279-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["New Treatments for Incontinence"],"prefix":"10.1053","volume":"22","author":[{"given":"Lara S.","family":"MacLachlan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Rovner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ackd.2015.03.003_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.003_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/(SICI)1520-6777(1999)18:5<419::AID-NAU2>3.0.CO;2-Z","article-title":"Stress urinary incontinence: prevalence among nulliparous compared with primiparous and grand multiparous premenopausal women","volume":"18","author":"Groutz","year":"1999","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"10.1053\/j.ackd.2015.03.003_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/jech.53.8.453","article-title":"Urinary incontinence in middle aged women: childhood enuresis and other lifetime risk factors in a British prospective cohort","volume":"53","author":"Kuh","year":"1999","journal-title":"J Epidemiol Community Health"},{"key":"10.1053\/j.ackd.2015.03.003_bib4","series-title":"Incontinence","first-page":"199","article-title":"Epidemiology and natural history of urinary incontinence (UI)","author":"Arnold","year":"1999"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.003_bib5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0022-5347(17)45194-9","article-title":"Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly","volume":"136","author":"Diokno","year":"1986","journal-title":"J Urol"},{"issue":"6","key":"10.1053\/j.ackd.2015.03.003_bib6","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1067\/mob.2003.353","article-title":"Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on epidemiologic issues in urinary incontinence in women","volume":"188","author":"Brown","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.003_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1207\/s15327655jchn0501_4","article-title":"Differences in physical health, social interaction, and personal adjustment between continent and incontinent homebound aged women","volume":"5","author":"Breakwell","year":"1988","journal-title":"J Community Health Nurs"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.003_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/pr.56.4.4","article-title":"Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence","volume":"56","author":"Andersson","year":"2004","journal-title":"Pharmacol Rev"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.003_bib9","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0022-5347(01)64113-2","article-title":"Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years","volume":"158","author":"Malmsten","year":"1997","journal-title":"J Urol"},{"issue":"suppl 6","key":"10.1053\/j.ackd.2015.03.003_bib10","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.juro.2012.09.079","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline","volume":"188","author":"Gormley","year":"2012","journal-title":"J Urol"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.003_bib11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1532-5415.2000.tb04692.x","article-title":"Combined behavioral and drug therapy for urge incontinence in older women","volume":"48","author":"Burgio","year":"2000","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.003_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMoa0806375","article-title":"Weight loss to treat urinary incontinence in overweight and obese women","volume":"360","author":"Subak","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.ackd.2015.03.003_bib13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/0003-4819-156-12-201206190-00436","article-title":"Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review","volume":"156","author":"Shamliyan","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.003_bib14","first-page":"CD003781","article-title":"Anticholinergic drugs versus placebo for overactive bladder syndrome in adults","author":"Nabi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.003_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/nau.20826","article-title":"Effects of CL316,243, a beta 3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat","volume":"29","author":"Aizawa","year":"2010","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.003_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/nau.10130","article-title":"Role of beta-adrenoceptor subtypes in mediating relaxation of the pig bladder trigonal muscle in\u00a0vitro","volume":"22","author":"Yamanishi","year":"2003","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"10.1053\/j.ackd.2015.03.003_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/ijcp.12194","article-title":"Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies","volume":"67","author":"Nitti","year":"2013","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.003_bib18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.juro.2013.02.104","article-title":"Selective beta(3)-adrenoceptor agonists for the treatment of overactive bladder","volume":"190","author":"Andersson","year":"2013","journal-title":"J Urol"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.003_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.eururo.2014.02.012","article-title":"Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony)","volume":"67","author":"Abrams","year":"2015","journal-title":"Eur Urol"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.003_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.mou.0000232047.87803.1e","article-title":"Current opinion on the working mechanisms of neuromodulation in the treatment of lower urinary tract dysfunction","volume":"16","author":"van der Pal","year":"2006","journal-title":"Curr Opin Urol"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.003_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00003081-200203000-00023","article-title":"Neuromodulation techniques for the treatment of the overactive bladder","volume":"45","author":"Kohli","year":"2002","journal-title":"Clin Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.003_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.juro.2009.05.045","article-title":"Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial","volume":"182","author":"Peters","year":"2009","journal-title":"J Urol"},{"issue":"6","key":"10.1053\/j.ackd.2015.03.003_bib23","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.juro.2012.11.175","article-title":"Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study","volume":"189","author":"Peters","year":"2013","journal-title":"J Urol"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.003_bib24","first-page":"198","article-title":"Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art","volume":"8","author":"Nitti","year":"2006","journal-title":"Rev Urol"},{"issue":"6","key":"10.1053\/j.ackd.2015.03.003_bib25","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","article-title":"Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity","volume":"187","author":"Ginsberg","year":"2012","journal-title":"J Urol"},{"issue":"6","key":"10.1053\/j.ackd.2015.03.003_bib26","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.003_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"issue":"19","key":"10.1053\/j.ackd.2015.03.003_bib28","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1208872","article-title":"Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence","volume":"367","author":"Visco","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.ackd.2015.03.003_bib29","first-page":"CD005493","article-title":"Botulinum toxin injections for adults with overactive bladder syndrome","author":"Duthie","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.003_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1442-2042.2012.03035.x","article-title":"Botulinum toxin injection for lower urinary tract dysfunction","volume":"20","author":"Kuo","year":"2013","journal-title":"Int J Urol"},{"issue":"10","key":"10.1053\/j.ackd.2015.03.003_bib31","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2165\/00003495-200666100-00001","article-title":"Botulinum toxin for the management of bladder dysfunction","volume":"66","author":"Schurch","year":"2006","journal-title":"Drugs"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.003_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ucl.2004.09.004","article-title":"How sacral nerve stimulation neuromodulation works","volume":"32","author":"Leng","year":"2005","journal-title":"Urol Clin North Am"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.003_bib33","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.juro.2007.07.032","article-title":"Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study","volume":"178","author":"van Kerrebroeck","year":"2007","journal-title":"J Urol"},{"issue":"8","key":"10.1053\/j.ackd.2015.03.003_bib34","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/nau.21147","article-title":"Magnetic resonance imaging following InterStim(R): an institutional experience with imaging safety and patient satisfaction","volume":"30","author":"Chermansky","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1053\/j.ackd.2015.03.003_bib35","series-title":"MRI guidelines for InterStim therapy neurostimulation systems","year":"2012"},{"issue":"9518","key":"10.1053\/j.ackd.2015.03.003_bib36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(06)68438-9","article-title":"Tissue-engineered autologous bladders for patients needing cystoplasty","volume":"367","author":"Atala","year":"2006","journal-title":"Lancet"},{"key":"10.1053\/j.ackd.2015.03.003_bib37","first-page":"CD005654","article-title":"Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. [e-pub ahead of print, May 14, 2014]","author":"Dumoulin","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.003_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.amjopharm.2005.03.004","article-title":"Duloxetine for management of stress urinary incontinence","volume":"3","author":"Guay","year":"2005","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.003_bib39","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1097\/01.ju.0000103688.83606.06","article-title":"Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended followup","volume":"171","author":"Chrouser","year":"2004","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.003_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.juro.2008.09.032","article-title":"Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study","volume":"181","author":"Ghoniem","year":"2009","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.003_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0090-4295(01)01148-7","article-title":"A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere","volume":"58","author":"Lightner","year":"2001","journal-title":"Urology"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.003_bib42","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.urology.2007.01.050","article-title":"Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence","volume":"69","author":"Mayer","year":"2007","journal-title":"Urology"},{"key":"10.1053\/j.ackd.2015.03.003_bib43","series-title":"Urinary Incontinence in Adults: Clinical Practice Guideline","year":"1992"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.003_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00192-012-1823-y","article-title":"Population-based trends in ambulatory surgery for urinary incontinence","volume":"24","author":"Suskind","year":"2013","journal-title":"Int Urogynecol J"},{"issue":"5","key":"10.1053\/j.ackd.2015.03.003_bib45","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.juro.2010.02.2369","article-title":"Update of AUA guideline on the surgical management of female stress urinary incontinence","volume":"183","author":"Dmochowski","year":"2010","journal-title":"J Urol"},{"key":"10.1053\/j.ackd.2015.03.003_bib46","series-title":"Campbell-Walsh Urology","first-page":"2115","article-title":"Slings: autologous, biologic, synthetic, and midurethral","author":"Dmochowski","year":"2012"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.003_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MOU.0b013e328354a754","article-title":"Vaginal mesh update: a look at the issues","volume":"22","author":"Winters","year":"2012","journal-title":"Curr Opin Urol"},{"key":"10.1053\/j.ackd.2015.03.003_bib48","series-title":"Campbell-Walsh Urology","first-page":"2047","article-title":"Retropubic suspension surgery for incontinence in women","author":"Chapple","year":"2012"},{"issue":"6","key":"10.1053\/j.ackd.2015.03.003_bib49","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.juro.2013.06.042","article-title":"A randomized, controlled clinical trial of a novel intravesical pressure attenuation device for the treatment of stress urinary incontinence","volume":"190","author":"Rovner","year":"2013","journal-title":"J Urol"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.003_bib50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.juro.2012.09.028","article-title":"Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study","volume":"189","author":"Carr","year":"2013","journal-title":"J Urol"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.003_bib51","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/nau.22404","article-title":"Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2-year follow-up of a Polish investigation","volume":"33","author":"Stangel-Wojcikiewicz","year":"2014","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"10.1053\/j.ackd.2015.03.003_bib52","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.juro.2014.02.047","article-title":"Autologous muscle derived cells for treatment of stress urinary incontinence in women","volume":"192","author":"Peters","year":"2014","journal-title":"J Urol"},{"key":"10.1053\/j.ackd.2015.03.003_bib53","series-title":"Campbell-Walsh Urology","first-page":"2290","article-title":"Surgical procedures for sphincteric incontinence in the male: the artificial genitourinary sphincter and perineal sling procedures","author":"Wessells","year":"2012"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.003_bib54","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0022-5347(17)61055-3","article-title":"Clean, intermittent self-catheterization in the treatment of urinary tract disease","volume":"107","author":"Lapides","year":"1972","journal-title":"J Urol"},{"issue":"3","key":"10.1053\/j.ackd.2015.03.003_bib55","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-5347(05)67800-7","article-title":"Effect of bladder management on urological complications in spinal cord injured patients","volume":"163","author":"Weld","year":"2000","journal-title":"J Urol"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.003_bib56","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0022-5347(05)67730-0","article-title":"Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients","volume":"163","author":"Weld","year":"2000","journal-title":"J Urol"},{"key":"10.1053\/j.ackd.2015.03.003_bib57","first-page":"234","volume":"Vol. 27","author":"Lai","year":"2008"},{"issue":"4","key":"10.1053\/j.ackd.2015.03.003_bib58","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0022-5347(05)67157-1","article-title":"Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury","volume":"164","author":"Esclarin De Ruz","year":"2000","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.ackd.2015.03.003_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00005392-200101000-00004","article-title":"Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation","volume":"165","author":"Jonas","year":"2001","journal-title":"J Urol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559515000397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559515000397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T01:24:58Z","timestamp":1566869098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559515000397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1548559515000397"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2015.03.003","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Treatments for Incontinence","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2015.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}